19 May 2013
Keywords: beta, blockers, safe, heart, failure, new, analysis
Article | 17 February 2003
A new analysis of data from the COPERNICUS trial of Roche andGlaxoSmithKline's beta blocker carvedilol has revealed that the drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 February 2003
17 May 2013
© 2013 thepharmaletter.com